PL
EW icon

Perpetual Ltd’s Edwards Lifesciences EW Stock Holding History

Perpetual Ltd’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$473K Buy
5,229
+79
+2% +$6.62K 0.01% 334
2026
Q1 		$412K Buy
5,150
+674
+15% +$55.6K 0.01% 346
2025
Q4 		$382K Buy
+4,476
New +$367K 0.01% 342
2024
Q3 		– Sell
-2,292
Closed -$212K – 442
2024
Q2 		$212K Sell
2,292
-183
-7% -$16.2K ﹤0.01% 413
2024
Q1 		$236K Buy
+2,475
New +$208K ﹤0.01% 412
2023
Q3 		– Sell
-2,308
Closed -$218K – 472
2023
Q2 		$218K Buy
+2,308
New +$201K ﹤0.01% 452
2020
Q3 		$8.45M Buy
105,858
+8,718
+9% +$680K 0.61% 51
2020
Q2 		$6.71M Hold
97,140
– – 0.63% 42
2020
Q1 		$6.11M Buy
+97,140
New +$7.01M 0.86% 28
2016
Q4 		– Sell
-244,050
Closed -$9.81M – 151
2016
Q3 		$9.81M Sell
244,050
-21,720
-8% -$818K 0.8% 28
2016
Q2 		$8.84M Buy
265,770
+24,810
+10% +$849K 0.88% 30
2016
Q1 		$7.08M Hold
240,960
– – 0.72% 41
2015
Q4 		$6.34M Buy
240,960
+105,660
+78% +$2.74M 0.71% 45
2015
Q3 		$3.21M Buy
135,300
+59,520
+79% +$1.44M 0.38% 69
2015
Q2 		$1.8M Buy
75,780
+2,700
+4% +$60.9K 0.21% 97
2015
Q1 		$1.74M Hold
73,080
– – 0.2% 99
2014
Q4 		$1.55M Buy
73,080
+9,840
+16% +$198K 0.18% 134
2014
Q3 		$1.08M Buy
63,240
+13,740
+28% +$217K 0.12% 136
2014
Q2 		$708K Buy
49,500
+15,060
+44% +$204K 0.06% 152
2014
Q1 		$426K Hold
34,440
– – 0.06% 158
2013
Q4 		$377K Sell
34,440
-3,360
-9% -$37.9K 0.05% 173
2013
Q3 		$439K Hold
37,800
– – 0.06% 168
2013
Q2 		$423K Buy
+37,800
New +$447K 0.06% 168

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
TIM
Triodos Investment Management Driebergen-Rijsenburg, Netherlands $1.64B AUM 37.98% 1-Year Est. Return

Perpetual Ltd's EW Position: Q2 2026 in Review

Perpetual Ltd increased its Edwards Lifesciences (EW) stake by 1.5% in Q2 2026, buying an estimated $6.62K and bringing the position to 5,229 shares worth $473K. The position accounts for 0.01% of the portfolio, ranked #334.

Perpetual Ltd first reported a position in EW in Q2 2013 and has held it in 23 quarters since. The position peaked at $9.81M in Q3 2016. 494 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Perpetual Ltd held 5,229 shares of Edwards Lifesciences worth $473K as of Q2 2026.
  • Perpetual Ltd bought 79 Edwards Lifesciences shares in Q2 2026, an estimated $6.62K.
  • Edwards Lifesciences made up 0.01% of Perpetual Ltd's portfolio in Q2 2026, its #334 holding.
  • Perpetual Ltd first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 23 quarters since.
  • Perpetual Ltd's Edwards Lifesciences position peaked at $9.81M in Q3 2016.
  • 494 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.